Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

FDA allows accelerated review for rivals to over-priced drugs

FDA allows accelerated review for rivals to over-priced drugs per pill, and hefty price hikes for two cardiovascular drugs sold by Valeant.

AZ offloads more products in slimming drive

AZ offloads more products in slimming drive Other recent examples include the divestment of inflammatory bowel disease therapy Entocort (budesonide) outside the US to Tillotts Pharma inand the sale of psoriasis candidate brodalumab to Valeant.

As CEO returns, Valeant admits SEC probe

As CEO returns, Valeant admits SEC probe The bank's report acknowledged, however, a change in Valeant's strategy of late. ... Valeant said it has less than 1% of the market for DHE 45 and had implemented the price increase to keep production of the drug viable.

Researchers say 'neurostatins' may ward off Alzheimer's

Researchers say 'neurostatins' may ward off Alzheimer's Bexarotene, which is sold by Eisai in Europe and Valeant Pharma in the US as Targretin, is an approved treatment for lymphoma and according to the research team is the first

Valeant names Schiller interim CEO as Pearson battles illness

Valeant names Schiller interim CEO as Pearson battles illness Valeant has named Howard Schiller as a stand-in for chief executive Michael Pearson, who was hospitalised over the holiday period. ... The appointment of Schiller - a former chief financial officer at Valeant - has dashed hopes that Pearson would make a

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics